Showing results (111-120 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2014
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid populationMachaon Bonafede, George J Joseph, Neel Shah, et al.Clinicoeconomics and Outcomes Research : CEOR|September 27, 2014
Adherence and resource use among patients treated with biologic drugs: findings from BEETLE studyLuca Degli Esposti, Diego Sangiorgi, Valentina Perrone, et al.Clinicoeconomics and Outcomes Research : CEOR|October 7, 2014
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health ServiceUmberto Restelli, Massimo Andreoni, Andrea Antinori, et al.Clinicoeconomics and Outcomes Research : CEOR|July 23, 2014
Cost-effectiveness of continuous erythropoietin receptor activator in anemiaHolger SchmidClinicoeconomics and Outcomes Research : CEOR|November 5, 2013
A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trendsNikolaos Maniadakis, Vasiliki Kapaki, Louiza Damianidi, et al.Clinicoeconomics and Outcomes Research : CEOR|August 23, 2013
Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in SwedenJaro Wex, Ahmed M Abou-SettaClinicoeconomics and Outcomes Research : CEOR|August 23, 2013
Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective studyAlan J Bank, Christopher Obetz, Ann Konrardy, et al.Clinicoeconomics and Outcomes Research : CEOR|September 17, 2013
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the USTimothy Juday, Todd Correll, Ayanna Anene, et al.Clinicoeconomics and Outcomes Research : CEOR|January 16, 2016
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulationGiovanni Cenderello, Stefania Artioli, Claudio Viscoli, et al.Clinicoeconomics and Outcomes Research : CEOR|January 1, 2016
Cost-effectiveness of minimally invasive sacroiliac joint fusionDaniel J Cher, Melissa A Frasco, Renée Jg Arnold, et al.Pageof 102